Other languages PCI Biotech Holding ASA

Equities

PCIB

NO0010405640

Real-time Oslo Bors Other stock markets 10:45:00 2024-04-30 am EDT			5-day change	1st Jan Change
1.586 ^NOK	+2.32%		-7.79%	-24.30%

Feb. 14	PCI Biotech Holding ASA Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Pci Biotech Initiates Field Testing of Its Proprietary Technology for Gene Therapy Manufacturing	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

PCI Biotech Holding ASA Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 14
Pci Biotech Initiates Field Testing of Its Proprietary Technology for Gene Therapy Manufacturing	23-10-13
PCI Biotech Holding ASA Announces European Patent Office Intends to Grant A New Patent Covering Delivery of mRNA	23-09-07
PCI Biotech Holding ASA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-31
PCI Biotech Holding ASA Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12
PCI Biotech Holding ASA Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-16
PCI Biotech Holding ASA Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-02-16
PCI Biotech Holding ASA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-23
PCI Biotech Holding ASA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-31
PCI Biotech Announces PH II Clinical Trail Update	22-08-18
PCI Biotech Holding ASA Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-11
PCI Biotech CEO to Step Down to Join Exact Therapeutics	22-03-28
PCI Biotech Holding ASA Announces Resignation on Per Walday as Chief Executive Officer	22-03-28
PCI Biotech Holding ASA Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-18
PCI Biotech Holding ASA Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	22-02-18
PCI Biotech Loses 10% As It Discontinues Cancer Trial To Focus On Immunotherapies	22-01-24
PCI Biotech Holding ASA Provides Update on the RELEASE Trial	22-01-24
PCI Biotech Announces Publication of Preclinical Tuberculosis Results	22-01-11
Norway's PCI Biotech, South Korea-based MDimune Join Preclinical Research Partnership	22-01-05
PCI Biotech and MDimune Announce Research Collaboration Agreement	22-01-05

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages PCI Biotech Holding ASA

Equities

PCIB

NO0010405640

Other languages

Filters